-
C-reactive protein levels are stronger predictors of first cardiovascular events than low-density lipoprotein cholesterol levels.
-
The excess risk of Achilles tendon disorders attributable to fluoroquinolone use was estimated to be 3.2 cases per 1000 patient-years, with most of that increase accounted for by patients 60 years of age and older who concomitantly receive corticosteroids.
-
The FDA has approved Atomoxetine (previously named tomoxetine), the first nonstimulant/noncontrolled drug to be approved for the treatment of attention-deficit/hyperactivity disorder (ADHD).
-
The tracing in the Figure was obtained from a 59-year-old woman with a long history of smoking. She presented with acute dyspnea and atypical chest pain. Because of moderate respiratory difficulty, this was the best quality tracing obtainable. In full acknowledgment of its suboptimal technical quality, how would you interpret this ECG? What findings may be of potential concern?
-
Udani J, Spar M. Green tea for weight loss. Altern Med Alert 2003;6(2):16-19.
-
La Puma J. Treatment and management of pediatric obesity. Altern Med Alert 2003;6(2):23.
-
The vast majority of Americans using complementary therapies are those seeking relief from some kind of pain: arthritis, chronic back pain, and musculoskeletal pain. Arthritis pain alone has driven more Americans to seek complementary and alternative medicine (CAM) therapies than any other single affliction.
-
Marcolina ST. Apitherapy: What's the buzz? Bee venom therapy for arthritis and multiple sclerosis. Altern Med Alert 2003;6(2):13-16.
-
O'Mathuna DP. Testosterone and andropause. Altern Med Alert 2003;6(2):19-22.
-
La Puma J. Dietary strategies for CHD prevention. Altern Med Alert 2003;6(2):22-23.
